These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 18709567

  • 1. U-shaped dose response in behavioral pharmacology: historical foundations.
    Calabrese EJ.
    Crit Rev Toxicol; 2008; 38(7):591-8. PubMed ID: 18709567
    [Abstract] [Full Text] [Related]

  • 2. Dose-response features of neuroprotective agents: an integrative summary.
    Calabrese EJ.
    Crit Rev Toxicol; 2008; 38(4):253-348. PubMed ID: 18432419
    [Abstract] [Full Text] [Related]

  • 3. Alzheimer's disease drugs: an application of the hormetic dose-response model.
    Calabrese EJ.
    Crit Rev Toxicol; 2008; 38(5):419-51. PubMed ID: 18568864
    [Abstract] [Full Text] [Related]

  • 4. Pain and u-shaped dose responses: occurrence, mechanisms, and clinical implications.
    Calabrese EJ.
    Crit Rev Toxicol; 2008; 38(7):579-90. PubMed ID: 18709566
    [Abstract] [Full Text] [Related]

  • 5. The emergence of behavioral pharmacology.
    Barrett JE.
    Mol Interv; 2002 Dec; 2(8):470-5. PubMed ID: 14993396
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological enhancement of neuronal survival.
    Calabrese EJ.
    Crit Rev Toxicol; 2008 Dec; 38(4):349-89. PubMed ID: 18432420
    [Abstract] [Full Text] [Related]

  • 7. Historical blunders: how toxicology got the dose-response relationship half right.
    Calabrese EJ.
    Cell Mol Biol (Noisy-le-grand); 2005 Dec 14; 51(7):643-54. PubMed ID: 16359616
    [Abstract] [Full Text] [Related]

  • 8. Hormesis, adaptation, and the sandpile model.
    Stark M.
    Crit Rev Toxicol; 2008 Dec 14; 38(7):641-4. PubMed ID: 18709573
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Astrocytes: adaptive responses to low doses of neurotoxins.
    Calabrese EJ.
    Crit Rev Toxicol; 2008 Dec 14; 38(5):463-71. PubMed ID: 18568866
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hormesis: why it is important to toxicology and toxicologists.
    Calabrese EJ.
    Environ Toxicol Chem; 2008 Jul 14; 27(7):1451-74. PubMed ID: 18275256
    [Abstract] [Full Text] [Related]

  • 13. Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications.
    Calabrese EJ.
    Crit Rev Toxicol; 2005 Jul 14; 35(2-3):89-295. PubMed ID: 15839378
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Control of drug-taking behavior by schedules of reinforcement.
    Kelleher RT, Goldberg SR.
    Pharmacol Rev; 1975 Sep 14; 27(3):291-9. PubMed ID: 817303
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate.
    Calabrese EJ.
    Crit Rev Toxicol; 2008 Sep 14; 38(6):489-542. PubMed ID: 18615308
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug effects and concurrent performances.
    Catania AC.
    Pharmacol Rev; 1975 Sep 14; 27(3):385-94. PubMed ID: 1223911
    [No Abstract] [Full Text] [Related]

  • 20. When to respond? And how much? Temporal control and response output on mixed-fixed-interval schedules with unequally probable components.
    Whitaker S, Lowe CF, Wearden JH.
    Behav Processes; 2008 Jan 14; 77(1):33-42. PubMed ID: 17628349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.